News Zhejiang Shengda Bio-Pharm Co., Ltd.

Equities

603079

CNE100002W43

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
12.87 ^CNY	+10.00%		+37.65%	-11.67%

04-19	Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-19	Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-19	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	04-01	CI
China stocks rise as strength in banks offsets developers' falls	03-29	RE
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	01-02	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	23-10-09	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	23-07-03	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. announces an Equity Buyback for CNY 34 million worth of its shares.	23-05-08	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. authorizes a Buyback Plan.	23-04-27	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. announced that it expects to receive CNY 500 million in funding	23-03-22	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Shengda Bio-Pharm Co., Ltd.

Equities

603079

CNE100002W43

Summary

Filters